Join
Live feed
·
INSIDERFilingvia Quantisnow
Rocket Pharmaceuticals Inc. logo

General Counsel Wilson Martin sold $4,839 worth of shares (1,592 units at $3.04), decreasing direct ownership by 1% to 135,462 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
RCKT· Rocket Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RCKT (Rocket Pharmaceuticals Inc.) and more on Quantisnow.